<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00510237</url>
  </required_header>
  <id_info>
    <org_study_id>ATN 068</org_study_id>
    <nct_id>NCT00510237</nct_id>
  </id_info>
  <brief_title>Intervention for Newly Diagnosed Youth With HIV</brief_title>
  <official_title>Intervention Development for Newly Diagnosed Youth With HIV</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of North Carolina, Chapel Hill</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Drug Abuse (NIDA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institute of Mental Health (NIMH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of North Carolina, Chapel Hill</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will pilot test an HIV intervention for newly diagnosed youth (diagnosed for less
      than 15 months) to assess its acceptability and feasibility preliminary to and leading up to
      a full-scale, randomized trial. The general focus of the intervention is to aid in the
      psychosocial adjustment of adolescents who have recently been diagnosed with HIV.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The intervention will consist of a combination of individual and group-based sessions in
      which the youth will participate. This combination allows for more intensive individualized
      attention as well as supportive group sessions. Youth will first participate in two
      individual sessions, followed by nine group sessions, and end with one additional individual
      session.

      Individual Session I: Orientation I

      Part A - meet with interventionist for ecological assessment, rapport building, and
      preparation for meeting with medical provider Part B - meet with medical provider to answer
      HIV specific medical questions (i.e., transmission information, viral load/t-cells,
      opportunistic infections,etc.). The interventionist will be present in Part B as well.

      Individual Session II: Orientation II

      Part A - meet with interventionist for continued debriefing, question/answer, preparation for
      group participation.

      Part B - meet with peer facilitator to discuss individual experiences living with HIV,
      rapport building, peer-specific questions. The interventionist will be present in Part B as
      well.

      Individual session III: Wrap-up and Action Planning (to take place after group sessions are
      complete)

      Part A - action plan with linkage to identified agencies via facilitated referrals Part B -
      (optional) support building - participants may bring parents, partner, friend, or other
      potential source of support for question/answer session with interventionist

      Session I: Developing Group Cohesion

      - Icebreaker, team building, group rules, facilitation of group &quot;ownership&quot; by participants.

      Session II: Disclosure, Stigma &amp; Relationships

        -  Disclosure to family, friends, peers and co-workers as well as dealing with stigma
           associated with HIV/AIDS;

        -  Concerns about current or future romantic and/or sexual relationships, including
           discussion of safer sex, condom use, sero-discordant couples.

      Session III: Preparing for Medical Intervention

      - Working with medical providers, an overview of clinic appointments and expectations
      surrounding attendance, a preliminary discussion of medications, side effects, and medical
      management as well as strategies for adherence.

      Session IV: Healthy Living

        -  Issues related to drugs and alcohol;

        -  Leisure activities such as sports and entertainment;

        -  Self-care including nutrition and exercise;

        -  The importance of school and work.

      Session V: Stress Reduction/Relaxation &amp; Spirituality

        -  Techniques including deep breathing, progressive muscle relaxation, visualization,
           meditation and self-hypnosis;

        -  Self-care including complimentary therapies such as massage and acupuncture

        -  Spirituality;

        -  Planning social outings and activities.

      Session VI: Gender Specific

        -  Males: issues surrounding sexuality and sexual orientation, male role of caring for
           self, loved ones, and the community;

        -  Females: issues surrounding sexuality, pregnancy and parenting, female role of caring
           for self, loved ones, and the community.

      Session VII: Self-Esteem/Self-Worth

      - Strategies to improve self-esteem and self-worth;

      Session VIII: Legal Issues/Advocacy

        -  Legal rights and advocacy;

        -  Linkage to community advocacy groups;

        -  Preparing to become a speaker/advocate;

        -  Health insurance/life insurance.

      Session IX: Future Planning

      - Planning for the future including issues related to work and school (e.g., job application
      process, applying for financial aid), job training and career choices.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2007</start_date>
  <completion_date type="Actual">January 2009</completion_date>
  <primary_completion_date type="Actual">June 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The best procedures for a larger trial (e.g. timing, content etc. of ACASI administration)</measure>
    <time_frame>7 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>The appropriateness of specific instruments proposed.</measure>
    <time_frame>7 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>The perceived sensitivity of measures to change over time.</measure>
    <time_frame>7 months</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>HIV</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>5-7 females per group at each of the four sites.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>5-7 males per group at each of the four sites.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>&quot;Adolescents Coping, Connecting, Empowering, and Protecting Together&quot; (Project ACCEPT)</intervention_name>
    <description>The intervention will consist of a combination of individual and group-based sessions in which the youth will participate. This combination allows for more intensive individualized attention as well as supportive group sessions. Youth will first participate in two individual sessions, followed by nine group sessions, and end with one additional individual session.</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        To be considered eligible for enrollment in ATN 068, a participant must meet the criteria
        listed below:

          -  Receive services at one of the 4 selected ATN sites or their community partners;

          -  HIV-infected as documented by medical record review or verbal verification with
             referring professional;

          -  Received HIV diagnosis less than 15 months ago as documented by medical record review
             or verbal verification with referring professional;

          -  Fall between the ages of 16-24 (inclusive) at the time of informed consent/assent;

          -  Must be willing to participate in the both the individual and group sessions;

          -  Give informed consent/assent for study participation.

        Exclusion Criteria:

        Participants who meet any of the exclusion criteria listed below are considered ineligible:

          -  Acquired HIV through perinatal infection;

          -  Presence of serious psychiatric symptoms (active hallucinations, thought disorder);

          -  Visibly distraught (suicidal, homicidal, exhibiting violent behavior);

          -  Intoxicated or under the influence of alcohol or other substances at the time of study
             enrollment.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>24 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sybil Hosek, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>John Stroger Jr. Hospital of Cook County</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Miami School of Medicine</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33101</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>John Stroger Jr. Hospital of Cook County</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Montefiore Medical Center</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10467</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Jude Children's Research Hospital</name>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <zip>38105</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.atnonline.org</url>
    <description>Website for the Adolescents Trials Network for HIV/AIDS Interventions</description>
  </link>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 31, 2007</study_first_submitted>
  <study_first_submitted_qc>July 31, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 1, 2007</study_first_posted>
  <last_update_submitted>March 2, 2017</last_update_submitted>
  <last_update_submitted_qc>March 2, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 6, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>HIV</keyword>
  <keyword>Adolescents newly diagnosed with HIV</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

